The estimated Net Worth of Andrew Pucher is at least $4.56 Milione dollars as of 18 March 2021. Mr. Pucher owns over 7,497 units of Tilray Brands Inc stock worth over $60,023 and over the last 5 years he sold TLRY stock worth over $0. In addition, he makes $4,495,130 as Chief Corporate Development Officer at Tilray Brands Inc.
Andrew has made over 5 trades of the Tilray Brands Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 7,497 units of TLRY stock worth $12,895 on 18 March 2021.
The largest trade he's ever made was exercising 30,024 units of Tilray Brands Inc stock on 18 March 2020 worth over $51,641. On average, Andrew trades about 10,002 units every 61 days since 2020. As of 18 March 2021 he still owns at least 34,897 units of Tilray Brands Inc stock.
You can see the complete history of Mr. Pucher stock trades at the bottom of the page.
Andrew Pucher serves as Chief Corporate Development Officer of the Company. From July 2009 to February 2019 Mr. Pucher was with Goldman Sachs, where he most recently served as Managing Director and Head of Canadian Diversified Investment Banking, which included coverage of the Canadian cannabis industry. Previously, Mr. Pucher was a member of Goldman Sachs’ Global Healthcare Investment Banking Group in New York. Mr. Pucher attended Simon Fraser University and obtained a JD/MBA from York University.
As the Chief Corporate Development Officer of Tilray Brands Inc, the total compensation of Andrew Pucher at Tilray Brands Inc is $4,495,130. There are 1 executives at Tilray Brands Inc getting paid more, with Irwin David Simon having the highest compensation of $13,683,999.
Andrew Pucher is 37, he's been the Chief Corporate Development Officer of Tilray Brands Inc since 2019. There are 12 older and no younger executives at Tilray Brands Inc. The oldest executive at Tilray Brands Inc is Christine St.Clare, 69, who is the Independent Director.
Andrew's mailing address filed with the SEC is 49 SPADINA AVENUE, SUITE 200, , TORONTO, A6, M4V 3E3.
Over the last 6 years, insiders at Tilray Brands Inc have traded over $92,844,538 worth of Tilray Brands Inc stock and bought 140,416 units worth $933,182 . The most active insiders traders include Irwin D Simon, Brendan Kennedy e Mitchell Gendel. On average, Tilray Brands Inc executives and independent directors trade stock every 13 days with the average trade being worth of $215,593. The most recent stock trade was executed by Irwin D Simon on 31 July 2024, trading 706,214 units of TLRY stock currently worth $1,433,614.
tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. we are the only gmp certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in australia, canada, the european union and the americas.
Tilray Brands Inc executives and other stock owners filed with the SEC include: